NOX1 and diabetic kidney disease: It has been shown that combined Nox1/4 inhibition with GKT137831 reduces vascular leukocytes infiltration in atherosclerosis [45], or suppresses proinflammatory and profibrotic processes in a model of diabetic nephropathy [46], both results are contrary to our study.